(Q40021085)

16 September 2017

title

Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia (English)

1 reference

16 September 2017

1 reference

6

Ellice S Lieberman

1 reference

16 September 2017

4

Colleen M Feltmate

1 reference

16 September 2017

Whitfield B Growdon

1

1 reference

16 September 2017

Adam J Wolfberg

2

1 reference

16 September 2017

Donald P Goldstein

3

1 reference

16 September 2017

Manuel E Chinchilla

5

1 reference

16 September 2017

Ross S Berkowitz

7

1 reference

16 September 2017

language of work or name

English

0 references

publication date

6 December 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

112

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

353-357

1 reference

Gestational trophoblastic disease epidemiology and trends

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Development of postmolar trophoblastic disease after partial molar pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

5-day methotrexate for women with metastatic gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Methotrexate infusion in low-risk gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

Gestational trophoblastic neoplasia: treatment outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.003

10.1016/J.YGYNO.2008.11.003

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference